Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 164 active Myelodysplastic Syndrome trials
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Study Type: Interventional Phase 2
Gene Therapy for Fanconi Anemia, Complementation Group A
Study Type: Interventional Phase 2
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Study Type: Interventional Phase 2
Study of REM-422 in Patients With AML or Higher Risk MDS
Study Type: Interventional Phase 1
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Study Type: Interventional Phase 2
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Study Type: Interventional Phase 1
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
Study Type: Interventional Early Phase 1
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
Study Type: Interventional Phase 3
There are 164 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now